Immunology and New Concepts in Immunotherapy
About us
Created in 2022, the INCIT(Immunology and New Concepts in Immunotherapy) research unit, directed by Frédéric Altare, is based on the desire to focus thescientific expertise of the immunology and immunotherapy teams on different pathological contexts: inflammation, cancer and infectious diseases.
Workforce
Publications since 2016
Doctoral students and post-docs
Locations - Nantes and Angers
Teams of specialists
INCIT brings together a wide range of immunology skills among its 4 teams, with a common objective:
To decipher the cellular and molecular mechanisms associated with immune responses to develop immunotherapeutic strategies.
Our news

ReNAissance: revolutionizing antiviral treatments with messenger RNA
ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.
"Enterotoxigenic bacteria, biofilms and colorectal cancer immunotherapy".
F. Altare's team has invited Prof. Franck Housseau (Johns Hopkins University) on May 28, 14.00. Seminar title: Enterotoxigenic bacteria, biofilms and colorectal cancer immunotherapy.
"When Antibiotics Fail: Understanding Bacterial Persistence During Infection".
The Angevine team has invited Charlotte Michaux from U1230 to Rennes on April 23 at 11.00. Title of her seminar: When Antibiotics Fail: Understanding Bacterial Persistence During Infection.
ReNAissance: revolutionizing antiviral treatments with messenger RNA
ReNAissance is one of the projects selected by the Impact Santé program, an initiative led by Inserm as part of France 2030. The aim of this program is to support the most daring, high-impact health research, by funding projects that push back the boundaries of current science and medicine.